Seres Therapeutics, Inc. Inventory, Work in Process, Gross
Seres Therapeutics, Inc. (MCRB) had Inventory, Work in Process, Gross of $48.06 million as of 2024-06-30, per its 10-Q filed 2024-08-13.
Discontinued › Balance Sheet › Assets › Assets, Current › Inventory, Net
us-gaap:InventoryWorkInProcess · last filed 2024-08-15
- 2024-06-30: Inventory, Work in Process, Gross $48.06M.
- 2024-03-31: Inventory, Work in Process, Gross $37.27M.
- 2023-12-31: Inventory, Work in Process, Gross $25.22M.
- 2023-09-30: Inventory, Work in Process, Gross $14.99M.
| Period end | Inventory, Work in Process, Gross |
|---|---|
| 2024-06-30 | $48.06M 10-Q · filed 2024-08-13 |
| 2024-03-31 | $37.27M 10-Q · filed 2024-05-08 |
| 2023-12-31 | $25.22M 8-K · filed 2024-08-15 |
| 2023-09-30 | $14.99M 10-Q · filed 2023-11-02 |
| 2023-06-30 | $4.75M 10-Q · filed 2023-08-08 |
| 2022-12-31 | $0.00 8-K · filed 2024-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B |